Teaser text

A leading capability in the development of biomaterials functionalised with biological signalling molecules for blood vessel repair and regeneration, for therapeutic application.

Body Text

Competitive advantage

Fundamental and multidisciplinary expertise in:

  • Synthetic and natural biomaterials
  • Blood vessel cell surface and extracellular matrix molecules
  • Recombinant protein expression
  • Biochemical, biophysical and cell-based functional assays
  • In vivo models


  • Developing next generation biomaterials that interface with the body to direct blood vessel and tissue repair

Successful outcomes

  • IP portfolio in methods to produce signalling molecules
  • Preclinical testing for novel vascular graft coating
  • Preclinical testing for diabetic wound healing
  • Coatings for prolonged platelet storage

Capabilities and facilities

  • State-of-the-art preclinical biomaterial and biological molecule development and testing laboratories encompassing in vitro and in vivo analyses

Our partners

  • Synedgen Inc
  • TriCol Biomedical
  • Diabetes Australia
  • Australian Red Cross Blood Service